Ishara Investments LP: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 2111609) · Explore on the interactive board
Ishara Investments LP disclosed 41 US equity positions worth $136.1m in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is ACAD at 7.6% of the reported book, followed by XERS, BMRN. The top ten holdings are 51.0% of the book, and the portfolio behaves like about 26 equal-weight positions. Versus the prior filing it opened 16 new positions, added to 13, reduced 8 and exited 11. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Ishara Investments LP own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 16 new, 13 added, 8 reduced, 11 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 7.6% | $10.4m | 410,000 | 233% | added |
| 2 | XERS XERIS BIOPHARMA HOLDINGS INC | Healthcare | 7.2% | $9.7m | 1,230,000 | 20% | added |
| 3 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 6.0% | $8.2m | 143,500 | 75% | added |
| 4 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 5.5% | $7.5m | 22,550 | 0% | held |
| 5 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 5.0% | $6.8m | 205,000 | 18% | added |
| 6 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 4.5% | $6.1m | 164,000 | – | new |
| 7 | INSM INSMED INC | Healthcare | 4.0% | $5.5m | 51,250 | – | new |
| 8 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 3.9% | $5.4m | 143,500 | – | new | |
| 9 | ZNTL ZENTALIS PHARMACEUTICALS INC | Healthcare | 3.7% | $5.0m | 1,025,000 | -17% | reduced |
| 10 | PCVX VAXCYTE INC | Healthcare | 3.5% | $4.8m | 82,000 | 43% | added |
| 11 | ANNX ANNEXON INC | Healthcare | 3.4% | $4.7m | 820,000 | 371% | added |
| 12 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 3.4% | $4.7m | 82,000 | -26% | reduced |
| 13 | TNXP TONIX PHARMACEUTICALS HLDG C | 3.2% | $4.3m | 338,250 | – | new | |
| 14 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 3.1% | $4.3m | 57,400 | – | new |
| 15 | AXSM AXSOME THERAPEUTICS INC. | Healthcare | 2.9% | $4.0m | 16,400 | -60% | reduced |
| 16 | CTNM CONTINEUM THERAPEUTICS INC | 2.5% | $3.4m | 205,000 | 44% | added | |
| 17 | LXRX LEXICON PHARMACEUTICALS INC | Healthcare | 2.2% | $3.1m | 1,271,000 | 41% | added |
| 18 | KURA KURA ONCOLOGY INC | Healthcare | 2.2% | $3.0m | 276,750 | – | new |
| 19 | DBVT DBV TECHNOLOGIES S A | 2.2% | $3.0m | 184,500 | 80% | added | |
| 20 | GMAB GENMAB A/S | Healthcare | 2.1% | $2.8m | 102,500 | 25% | added |
| 21 | CYTK CYTOKINETICS INC | Healthcare | 2.1% | $2.8m | 32,800 | – | new |
| 22 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 2.0% | $2.8m | 102,500 | 25% | added |
| 23 | SLN SILENCE THERAPEUTICS PLC | 1.8% | $2.4m | 55,350 | -61% | reduced | |
| 24 | NUVB NUVATION BIO INC | Healthcare | 1.5% | $2.1m | 369,000 | – | new |
| 25 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 1.4% | $1.9m | 328,000 | – | new |
| 26 | NKTR NEKTAR THERAPEUTICS | Healthcare | 1.4% | $1.9m | 26,650 | – | new |
| 27 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 1.2% | $1.7m | 30,750 | -46% | reduced |
| 28 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 1.2% | $1.7m | 32,800 | – | new |
| 29 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 1.1% | $1.5m | 5,125 | 0% | held |
| 30 | BEAM BEAM THERAPEUTICS INC | Healthcare | 1.0% | $1.4m | 41,000 | -29% | reduced |
| 31 | SION SIONNA THERAPEUTICS INC | Healthcare | 1.0% | $1.4m | 123,000 | 150% | added |
| 32 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 1.0% | $1.3m | 123,000 | 20% | added |
| 33 | NEWAMSTERDAM PHARMA COMPANY | 0.9% | $1.3m | 36,900 | 0% | held | |
| 34 | VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 0.9% | $1.2m | 2,460 | – | new |
| 35 | SPRY ARS PHARMACEUTICALS INC | Healthcare | 0.8% | $1.1m | 143,490 | – | new |
| 36 | MNPR MONOPAR THERAPEUTICS INC | 0.8% | $1.1m | 12,300 | – | new | |
| 37 | ERAS ERASCA INC | Healthcare | 0.6% | $751.1k | 41,000 | – | new |
| 38 | VERA VERA THERAPEUTICS INC | Healthcare | 0.3% | $439.8k | 10,250 | -88% | reduced |
| 39 | IMTX IMMATICS N.V | Healthcare | 0.2% | $311.5k | 30,750 | -80% | reduced |
| 40 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.2% | $244.2k | 768,750 | – | new |
| 41 | GOSS GOSSAMER BIO INC | Healthcare | 0.1% | $135.0k | 820,000 | 0% | held |
What did Ishara Investments LP sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| 4XC1 KALVISTA PHARMACEUTICALS INC | 17.7% | $5.6m |
| AM6 AMICUS THERAPEUTIC | 17.0% | $5.3m |
| VSTM VERASTEM INC | 13.8% | $4.3m |
| ARWR ARROWHEAD PHARMACEUTICALS IN | 11.0% | $3.5m |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | 10.3% | $3.2m |
| ARDX ARDELYX INC | 8.6% | $2.7m |
| CATALYST PHARMACEUTICALS INC | 6.5% | $2.0m |
| LGND LIGAND PHARMACEUTICALS INC | 5.2% | $1.6m |
| EWTX EDGEWISE THERAPEUTICS INC | 4.9% | $1.5m |
| IDYA IDEAYA BIOSCIENCES INC | 2.6% | $819.7k |
| PTCT PTC THERAPEUTICS INC | 2.2% | $698.3k |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 84.6% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Ishara Investments LP's portfolio?
Across every quarter Ishara Investments LP has filed, its median largest position is 7.5% of the book and its median top-ten weight is 51.0%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 11.0 completed holding spells, the median lasted 1.0 quarters; 41.0 positions are still open and their final length is unknown.